Simmunome Inc. vs Unlearn.AI

Simmunome Inc. logo

Simmunome Inc.

Move your pipeline forward, with confidence

10 employees · est. 2019 · Montreal, Canada

VS
Unlearn.AI logo

Unlearn.AI

Transforming clinical development by making every trial smarter with AI

74 employees · est. 2017 · San Francisco, United States

Unlearn.AI is the older company (2019 vs 2017); Unlearn.AI is the larger of the two.

Side-by-Side Comparison

Simmunome Inc. Unlearn.AI
Founded
2019 2017 older
Headquarters
Montreal, Canada San Francisco, United States
Employees
10 74 larger
Industry
AI, Biotechnology, Health Care AI, Biotechnology, Life Sciences
Funding Stage
Pre-Seed Series C
Total Funding
$2.00M $130.65M
Funding Rounds
3 6
Services
Efficacy Simulations, BioTarget™ Scoring Tool, Omic Signatures™, Predictive Biomarkers, Data Exploration Tool, AI Models, Custom Data Integration Trial Planning and Simulations, Anomaly Detection & Clinical Data Surveillance, Trial Analysis with Digital Twins, AI-powered Workspace for Clinical Development
Target Customers
Pharmaceutical Companies, Biotech Companies, Clinical Researchers, Medical Scientists Biopharma Companies, Clinical Trial Teams, Pharmaceutical Researchers, Healthcare Innovators, Neuroscience Specialists
Taxonomy
Clinical TrialsComputational BiologyDrug DiscoveryOncologyNervous SystemContract Research Organization +7 Biotech AIDigital Twin ServiceClinical TrialsPharmaceuticalsDeep LearningComputational Biology +7
Website
simmunome.com unlearn.ai
Simmunome Inc. logo

About Simmunome Inc.

Simmunome Inc. is a Canadian startup founded in 2019 that focuses on addressing the inefficiency of clinical trial success in the biotechnology and healthcare industries. With a slogan of "Move your pipeline forward, with confidence," Simmunome is at the forefront of leveraging AI to unravel biologi...

Unlearn.AI logo

About Unlearn.AI

Unlearn.AI is at the forefront of revolutionizing the clinical development sector with its expertise in AI. Founded in 2017, this US-based startup leverages artificial intelligence to enhance clinical trials, making them smarter and more efficient. Targeted within the rapidly evolving industries of...

Also comparing in this category

Comparing more than these two?

Get Simmunome Inc., Unlearn.AI and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Simmunome Inc. compare?

A PDF of Simmunome Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

Simmunome Inc. was founded in 2019, based in Montreal, Canada, with 10 employees. Simmunome Inc. is a Canadian startup founded in 2019 that focuses on addressing the inefficiency of clinical trial success in the biotechnology and healthcare industries. With a slogan of "Move your p. Unlearn.AI was founded in 2017, based in San Francisco, United States, with 74 employees. Unlearn.AI is at the forefront of revolutionizing the clinical development sector with its expertise in AI. Founded in 2017, this US-based startup leverages artificial intelligence to enhance clinical.
Simmunome Inc. has raised $2.00M and Unlearn.AI $130.65M. Latest stage: Simmunome Inc. Pre-Seed, Unlearn.AI Series C.
Both work in AI and Biotechnology and list clinical trials and computational biology among their focus areas.

Compare Simmunome Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Simmunome Inc. on 24 Mar 2025, and Unlearn.AI on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes